Literature DB >> 27473817

Geographic Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing Breast Conservation for Invasive Breast Cancer.

Erin F Gillespie1, Rayna K Matsuno1, Beibei Xu1, Daniel P Triplett1, Lindsay Hwang1, Isabel J Boero1, John P Einck1, Catheryn Yashar1, James D Murphy2.   

Abstract

PURPOSE: To evaluate geographic heterogeneity in the delivery of hypofractionated radiation therapy (RT) for breast cancer among Medicare beneficiaries across the United States. METHODS AND MATERIALS: We identified 190,193 patients from the Centers for Medicare and Medicaid Services Chronic Conditions Warehouse. The study included patients aged >65 years diagnosed with invasive breast cancer treated with breast conservation surgery followed by radiation diagnosed between 2000 and 2012. We analyzed data by hospital referral region based on patient residency ZIP code. The proportion of women who received hypofractionated RT within each region was analyzed over the study period. Multivariable logistic regression models identified predictors of hypofractionated RT.
RESULTS: Over the entire study period we found substantial geographic heterogeneity in the use of hypofractionated RT. The proportion of women receiving hypofractionated breast RT in individual hospital referral regions varied from 0% to 61%. We found no correlation between the use of hypofractionated RT and urban/rural setting or general geographic region. The proportion of hypofractionated RT increased in regions with higher density of radiation oncologists, as well as lower total Medicare reimbursements.
CONCLUSIONS: This study demonstrates substantial geographic heterogeneity in the use of hypofractionated RT among elderly women with invasive breast cancer treated with lumpectomy in the United States. This heterogeneity persists despite clinical data from multiple randomized trials proving efficacy and safety compared with standard fractionation, and highlights possible inefficiency in health care delivery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27473817      PMCID: PMC5014714          DOI: 10.1016/j.ijrobp.2016.05.006

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  33 in total

1.  Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer.

Authors:  Ami Vyas; Suresh Madhavan; Usha Sambamoorthi
Journal:  Breast Cancer Res Treat       Date:  2014-11-16       Impact factor: 4.872

Review 2.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  A population-based study of the fractionation of postlumpectomy breast radiation therapy.

Authors:  Allison Ashworth; Weidong Kong; Timothy Whelan; William J Mackillop
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-20       Impact factor: 7.038

4.  Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy.

Authors:  A L Bane; T J Whelan; G R Pond; S Parpia; G Gohla; A W Fyles; J-P Pignol; K I Pritchard; S Chambers; M N Levine
Journal:  Ann Oncol       Date:  2014-02-20       Impact factor: 32.976

5.  Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.

Authors:  Reshma Jagsi; Aaron D Falchook; Laura H Hendrix; Heather Curry; Ronald C Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-01       Impact factor: 7.038

Review 6.  Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

Authors:  Benjamin D Smith; Soren M Bentzen; Candace R Correa; Carol A Hahn; Patricia H Hardenbergh; Geoffrey S Ibbott; Beryl McCormick; Julie R McQueen; Lori J Pierce; Simon N Powell; Abram Recht; Alphonse G Taghian; Frank A Vicini; Julia R White; Bruce G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-16       Impact factor: 7.038

7.  Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.

Authors:  Timothy Whelan; Robert MacKenzie; Jim Julian; Mark Levine; Wendy Shelley; Laval Grimard; Barbara Lada; Himu Lukka; Francisco Perera; Anthony Fyles; Ethan Laukkanen; Sunil Gulavita; Veronique Benk; Barbara Szechtman
Journal:  J Natl Cancer Inst       Date:  2002-08-07       Impact factor: 13.506

8.  Distinguishing screening from diagnostic mammograms using Medicare claims data.

Authors:  Joshua J Fenton; Weiwei Zhu; Steven Balch; Rebecca Smith-Bindman; Paul Fishman; Rebecca A Hubbard
Journal:  Med Care       Date:  2014-07       Impact factor: 2.983

9.  Slowing the growth of health care costs--lessons from regional variation.

Authors:  Elliott S Fisher; Julie P Bynum; Jonathan S Skinner
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

10.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316

View more
  6 in total

1.  Are 5-Year Randomized Clinical Trial Results Sufficient for Implementation of Short-Course Whole Breast Radiation Therapy?

Authors:  Erin F Gillespie; Atif J Khan; Oren Cahlon; Lior Z Braunstein
Journal:  Pract Radiat Oncol       Date:  2021 Sep-Oct

2.  Hypofractionated Radiation Therapy for Breast Cancer: Financial Risk and Expenditures in the United States, 2008 to 2017.

Authors:  Loren Saulsberry; Chuanhong Liao; Dezheng Huo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-10-09       Impact factor: 8.013

3.  Disparities in Breast-Conserving Therapy for Non-Hispanic American Indian/Alaska Native Women Compared with Non-Hispanic White Women.

Authors:  Jennifer Erdrich; Felina Cordova-Marks; Angela R Monetathchi; Manxia Wu; Arica White; Stephanie Melkonian
Journal:  Ann Surg Oncol       Date:  2021-09-06       Impact factor: 5.344

4.  Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer.

Authors:  Kelsey L Corrigan; Xiudong Lei; Neelofur Ahmad; Isidora Arzu; Elizabeth Bloom; Stephen G Chun; Chelain Goodman; Karen E Hoffman; Melissa Joyner; Lauren Mayo; Melissa Mitchell; Kevin T Nead; George H Perkins; Valerie Reed; Jay P Reddy; Pamela Schlembach; Simona F Shaitelman; Michael C Stauder; Eric A Strom; Welela Tereffe; Lee Wiederhold; Wendy A Woodward; Benjamin D Smith
Journal:  Adv Radiat Oncol       Date:  2021-12-24

5.  Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018.

Authors:  Leticia M Nogueira; Helmneh M Sineshaw; Ahmedin Jemal; Craig E Pollack; Jason A Efstathiou; K Robin Yabroff
Journal:  JAMA Netw Open       Date:  2022-04-01

6.  Impact of care disparities in radiation oncology.

Authors:  Tasneem Kaleem; Grace Li Smith; Robert C Miller
Journal:  Adv Radiat Oncol       Date:  2017-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.